Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 11.473% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. Cc1occc1C(=O)Nc1cc(=O)n(C)c(=O)n1C
b. COc1ccc(C(=O)NCC(=O)N2CC=C(c3ccccc3)CC2)cc1OC
c. CCn1ncc(/C=N/NC(=O)c2ccc3c(c2)OCO3)c1C
Answer: c. CCn1ncc(/C=N/NC(=O)c2ccc3c(c2)OCO3)c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1ncc(/C=N/NC(=O)c2ccc3c(c2)OCO3)c1C
CCn1ncc(/C=N/NC(=O)c2ccc3c(c2)OCO3)c1C
N-[(E)-(1-ethyl-5-methylpyrazol-4-yl)methylideneamino]-1,3-benzodioxole-5-carboxamide